Moseley Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Moseley Investment Management's PFE Position: Q3 2024 in Review
Moseley Investment Management sold out of Pfizer (PFE) in Q3 2024, closing a stake of 12,595 shares — an estimated $352K sold.
Moseley Investment Management first reported a position in PFE in Q1 2019 and held it in 22 quarters. The position peaked at $1.62M in Q4 2021. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Moseley Investment Management reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
- Moseley Investment Management sold 12,595 Pfizer shares in Q3 2024, an estimated $352K.
- Moseley Investment Management first reported a position in Pfizer in Q1 2019 and held it in 22 quarters.
- Moseley Investment Management's Pfizer position peaked at $1.62M in Q4 2021.
- 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Moseley Investment Management's 13F filing for Q3 2024, filed 16 Oct 2024.